Felix Sebastian Nettersheim, Simon Brunel, Robert S. Sinkovits, Sujit Silas Armstrong, Payel Roy, Monica Billitti, Kouji Kobiyama, Ahmad Alimadadi, Sergei Bombin, Lihui Lu, Martina Zoccheddu, Mohammad Oliaeimotlagh, Chris A. Benedict, Alessandro Sette, Klaus Ley
{"title":"PD-1 and CD73 on naive CD4+ T cells synergistically limit responses to self","authors":"Felix Sebastian Nettersheim, Simon Brunel, Robert S. Sinkovits, Sujit Silas Armstrong, Payel Roy, Monica Billitti, Kouji Kobiyama, Ahmad Alimadadi, Sergei Bombin, Lihui Lu, Martina Zoccheddu, Mohammad Oliaeimotlagh, Chris A. Benedict, Alessandro Sette, Klaus Ley","doi":"10.1038/s41590-024-02021-6","DOIUrl":null,"url":null,"abstract":"<p>Vaccination with self- and foreign peptides induces weak and strong expansion of antigen-specific CD4<sup>+</sup> T cells, respectively, but the mechanism is not known. In the present study, we used computational analysis of the entire mouse major histocompatibility complex class II peptidome to test how much of the naive CD4<sup>+</sup> T cell repertoire specific for self-antigens was shaped by negative selection in the thymus and found that negative selection only partially explained the difference between responses to self and foreign. In naive uninfected and unimmunized mice, we identified higher expression of programmed cell death protein 1 (PD-1) and CD73 mRNA and protein on self-specific CD4<sup>+</sup> T cells compared with foreign-specific CD4<sup>+</sup> T cells. Pharmacological or genetic blockade of PD-1 and CD73 significantly increased the vaccine-induced expansion of self-specific CD4<sup>+</sup> T cells and their transcriptomes were similar to those of foreign-specific CD4<sup>+</sup> T cells. We concluded that PD-1 and CD73 synergistically limited CD4<sup>+</sup> T cell responses to self. These observations have implications for the development of tolerogenic vaccines and cancer immunotherapy.</p>","PeriodicalId":19032,"journal":{"name":"Nature Immunology","volume":"13 1","pages":""},"PeriodicalIF":27.7000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41590-024-02021-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Vaccination with self- and foreign peptides induces weak and strong expansion of antigen-specific CD4+ T cells, respectively, but the mechanism is not known. In the present study, we used computational analysis of the entire mouse major histocompatibility complex class II peptidome to test how much of the naive CD4+ T cell repertoire specific for self-antigens was shaped by negative selection in the thymus and found that negative selection only partially explained the difference between responses to self and foreign. In naive uninfected and unimmunized mice, we identified higher expression of programmed cell death protein 1 (PD-1) and CD73 mRNA and protein on self-specific CD4+ T cells compared with foreign-specific CD4+ T cells. Pharmacological or genetic blockade of PD-1 and CD73 significantly increased the vaccine-induced expansion of self-specific CD4+ T cells and their transcriptomes were similar to those of foreign-specific CD4+ T cells. We concluded that PD-1 and CD73 synergistically limited CD4+ T cell responses to self. These observations have implications for the development of tolerogenic vaccines and cancer immunotherapy.
期刊介绍:
Nature Immunology is a monthly journal that publishes the highest quality research in all areas of immunology. The editorial decisions are made by a team of full-time professional editors. The journal prioritizes work that provides translational and/or fundamental insight into the workings of the immune system. It covers a wide range of topics including innate immunity and inflammation, development, immune receptors, signaling and apoptosis, antigen presentation, gene regulation and recombination, cellular and systemic immunity, vaccines, immune tolerance, autoimmunity, tumor immunology, and microbial immunopathology. In addition to publishing significant original research, Nature Immunology also includes comments, News and Views, research highlights, matters arising from readers, and reviews of the literature. The journal serves as a major conduit of top-quality information for the immunology community.